Market Access & Pricing
Evidence
Rare Diseases
Advanced Therapies
Affordability
HTA/Payer
Big Data Analytics
Emerging Markets
Patient Advocacy
Medical Devices
"Great networking; very useful to hear from a mix of pharma companies and payers about market access and evidence requirements”
Head Global Pricing & Market Access, Vifor Pharma
“Great opportunity to gain payer and industry insights in several 'hot' topics”
Health Care Environment Manager EU Plus, Medac
"Excellent speakers and a really good chance to network“
Director Worldwide HEOR, BMS
"This has very good coverage of the topics & a look in the future. I always get away with more solutions and creativity"
Senior Director Market Access & Pricing Generics Europe, Teva